Search research articles
Contact Us
Filters
Showing results (111-120 of 191) with videos related to
Page
of 20
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 29, 1998
Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: a phase I study
S De Wit, E O'Doherty, J Edwards, et al.
International Journal of STD & AIDS
|
December 29, 2010
Virological response with fully active etravirine: pooled results from the DUET-1 and DUET-2 trials
N Clumeck, P Cahn, J-M Molina, et al.
Lancet (London, England)
|
February 9, 1985
Antibody to HTLV-III in blood donors in central Africa
P Van de Perre, D Munyambuga, G Zissis, et al.
Chemotherapy
|
January 1, 1979
Clinical and pharmacological evaluation of different preparations of oral erythromycin
J P Butzler, R Vanhoof, N Clumeck, et al.
AIDS (London, England)
|
October 6, 1999
Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, rotinavir or saquinavir
S De Wit, P Cassano, P Hermans, et al.
AIDS (London, England)
|
June 5, 1999
Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine
S De Wit, P Cassano, P Hermans, et al.
Journal of Clinical Microbiology
|
May 1, 1996
Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma
H Revets, D Marissens, S de Wit, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1984
Preliminary results on clinical and immunological effects of thymopentin in AIDS
N Clumeck, P van de Perre, F Mascart-Lemone, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 1, 1991
Biochemical thyroid profile in patients infected with the human immunodeficiency virus
P P Bourdoux, S A De Wit, G M Servais, et al.
Revue Medicale De Liege
|
June 20, 2017
[Professional fatigue syndrome (burnout) : Part 2 : from therapeutic management]
P Mesters, N Clumeck, S Delroisse, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 191) with videos related to
Sort By:
Page
of 20
Antimicrobial Agents and Chemotherapy
|
April 29, 1998
Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: a phase I study
S De Wit, E O'Doherty, J Edwards, et al.
International Journal of STD & AIDS
|
December 29, 2010
Virological response with fully active etravirine: pooled results from the DUET-1 and DUET-2 trials
N Clumeck, P Cahn, J-M Molina, et al.
Lancet (London, England)
|
February 9, 1985
Antibody to HTLV-III in blood donors in central Africa
P Van de Perre, D Munyambuga, G Zissis, et al.
Chemotherapy
|
January 1, 1979
Clinical and pharmacological evaluation of different preparations of oral erythromycin
J P Butzler, R Vanhoof, N Clumeck, et al.
AIDS (London, England)
|
October 6, 1999
Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, rotinavir or saquinavir
S De Wit, P Cassano, P Hermans, et al.
AIDS (London, England)
|
June 5, 1999
Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine
S De Wit, P Cassano, P Hermans, et al.
Journal of Clinical Microbiology
|
May 1, 1996
Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma
H Revets, D Marissens, S de Wit, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1984
Preliminary results on clinical and immunological effects of thymopentin in AIDS
N Clumeck, P van de Perre, F Mascart-Lemone, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 1, 1991
Biochemical thyroid profile in patients infected with the human immunodeficiency virus
P P Bourdoux, S A De Wit, G M Servais, et al.
Revue Medicale De Liege
|
June 20, 2017
[Professional fatigue syndrome (burnout) : Part 2 : from therapeutic management]
P Mesters, N Clumeck, S Delroisse, et al.
Page
of 20